SEC Form 4 reporting owner

Crombez Eric

Crombez Eric has filed 8 Form 4 transactions reported between January 26, 2026 and May 15, 2026, as Director of ABEONA THERAPEUTICS INC. and EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc..

Name as filed: Crombez Eric

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$396K
4 lines
Companies
2
with Form 4 filings
Latest transaction
May 15, 2026
transaction date

Roles and reported holdings

  • ABEOABEONA THERAPEUTICS INC.
    Jan 26, 2026 – May 15, 2026

    Director

    Held directly37,313 sh as of May 15, 2026 · Form 4

    24 months: $228K sold

  • RAREUltragenyx Pharmaceutical Inc.
    Mar 1, 2026 – May 5, 2026

    EVP and Chief Medical Officer

    Held directly111,189 sh as of May 5, 2026 · Form 4

    24 months: $169K sold

Transaction history

All 8 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
May 15, 2026ABEODirectorOpen-market saleCode S · direct26,143$145K@ $5.53Form 4
May 5, 2026RAREEVP and Chief Medical OfficerOpen-market saleCode S · direct344$9K@ $24.96Form 4
Apr 16, 2026RAREEVP and Chief Medical OfficerGrant or awardCode A · direct59,952—Form 4
Apr 16, 2026RAREEVP and Chief Medical OfficerGrant or awardCode A · direct34,674—Form 4
Mar 2, 2026RAREEVP and Chief Medical OfficerOpen-market saleCode S · direct7,029$160K@ $22.80Form 4
Mar 1, 2026RAREEVP and Chief Medical OfficerGrant or awardCode A · direct11,643—Form 4
Feb 2, 2026ABEODirectorOpen-market saleCode S · direct16,284$83K@ $5.09Form 4
Jan 26, 2026ABEODirectorGrant or awardCode A · direct37,313—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.